Evolution of anaerobe susceptibility testing in the United States.
Susceptibility testing of anaerobes has been described for approximately 45 years, some 15 years fewer than descriptions for aerobic organisms. During that time period, >16 methods, >16 media, and a host of other variables have been described in the United States literature, culminating in the most recent standards published by the National Committee for Clinical Laboratory Standards (NCCLS) in 2001. These new guidelines include a single agar dilution reference method as well as an alternative minimal inhibitory concentration method validated by extensive multilaboratory collaborative trials. In addition, the Food and Drug Administration-approved E-test has proved valuable as a user-friendly alternative to NCCLS methods. Highlights of the "evolution" of various methods, their variations and their failures, factors that affected the development of the current standards, and the rationale for susceptibility testing of anaerobes are discussed herein.
Hecht
David W
DW
Infectious Diseases Division, Loyola University Medical Center, and Hines VA Hospital, Maywood, IL, USA. Dhecht@lumc.edu
D001421:Bacteria, Anaerobic / Q000187:drug effects; D005075:Biological Evolution; D003470:Culture Media; D024881:Drug Resistance, Bacterial; D017408:Guidelines as Topic; D008826:Microbial Sensitivity Tests / Q000379:methods* / Q000592:standards; D015203:Reproducibility of Results; D014481:United States; D014486:United States Food and Drug Administration
D003470:Culture Media